June 14, 2019
June 10, 2019
The House Appropriations Committee by voice vote last week adopted an amendment to prohibit FDA from allowing scientists to conduct research involving gene-edited embryos and so-called three-parent in vitro fertilization.
June 7, 2019
The House on Tuesday passed and sent to President Trump a pandemic preparedness bill that would reauthorize funding for HHS programs designed to respond to biological and chemical threats, disasters, and emerging infectious diseases.
American Health Line rounds up the latest health care news in the states.
May 29, 2019
Fortune recently released its 65th annual ranked list of the 500 companies that generated the most revenue in the previous fiscal year, which included dozens of companies in the health care industry.
FDA on Friday approved the first gene therapy to treat a rare type of muscular atrophy in infants, and Novartis, which manufactures the drug, has said it will set the treatment's list price at $2.125 million—making it the highest-priced drug in the world.
May 20, 2019
CMS on Friday announced it is postponing a final policy decision that will outline how Medicare will cover CAR T-cell immunotherapies nationwide.
May 14, 2019
FDA on Friday released long-awaited final guidance on how the agency will determine whether biosimilar drugs can be interchanged with their brand-name biologic counterparts.
May 7, 2019
Forbes recently released its ranking of "America's Best Large Employers" and "America's Best Midsize Employers" for 2019, which included top employers among health care providers, insurers, biotech companies, and more.
April 30, 2019
Advisory Board. All rights reserved.